Coagulation in the mesangial area promotes ECM accumulation through factor V expression in MsPGN in rats

American Journal of Physiology - Renal Physiology

Volumn 287, Issue 4 56-4, 2004, Pages

  Liu, Ning ^a   Makino, Toshiaki ^a   Nogaki, Fumiaki ^a   Kusano, Hitoshi ^a   Suyama, Katsuo ^a   Muso, Eri ^b   Honda, Gisho ^a   Kita, Toru ^a   Ono, Takahiko ^a,c  

^a KYOTO UNIVERSITY   (Japan)

^b Kitano Hospital   (Japan)

^c UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Connective tissue growth factor; Experimental glomerulonephritis; Extracellular matrix components accumulation; Transforming growth factor

Indexed keywords

BLOOD CLOTTING FACTOR 5; COLLAGEN TYPE 4; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; MESSENGER RNA; NEUTRALIZING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; EXPERIMENTAL MODEL; EXTRACELLULAR MATRIX; GENE EXPRESSION; GLOMERULONEPHRITIS; GLOMERULUS; IMMUNOBLOTTING; MALE; MESANGIUM; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTHROMBIN TIME; RAT; WESTERN BLOTTING;

EID: 4644258834     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00322.2003     Document Type: Article

References (39)

1. Alpers CE, Hudkins KL, Gown AM, and Johnson RJ. Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int 41: 1134-1142, 1992.
2. Border WA and Noble NA. TGF-β in kidney fibrosis: a target for gene therapy. Kidney Int 51: 1388-1396, 1997.
3. Bruijn JA, Hogendoorn PC, Hoedemaeker PJ, and Fleuren GJ. The extracellular matrix in pathology. J Lab Clin Med 111: 140-149, 1988.
4. Burg M, Ostendorf T, Mooney A, Koch KM, and Floege J. Treatment of experimental mesangioproliferative glomerulonephritis with non-anti-coagulant heparin: therapeutic efficacy and safety. Lab Invest 76: 505-516, 1997.
5. Chomczynski P and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
6. Dale GL, Friese P, Batar P, Hamilton SF, Reed GL, Jackson KW, Clemetson KJ, and Alberio L. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 415: 175-179, 2002.
7. Erlich JH, Apostolopoulos J, Wun TC, Kretzmer KK, Holdsworth SR, and Tipping PG. Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbits. J Clin Invest 98: 325-335, 1996.
8. Floege J, Johnson RJ, Gordon K, Iida H, Pritzl P, Yoshimura A, Campbell C, Alpers CE, and Couser WG. Increased synthesis of expracellar matrix in mesangial proliferative nephritis. Kidney Int 40: 477-488, 1991.
9. Floege J, Eng E, Young BA, Couser WG, and Johnson RJ. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 43: 369-380, 1993.
10. Hattori T, Shindo S, Hisada T, Fujitsuka N, Hibino T, Terazono Y, and Maruno M. Effects of Onpi-to (TJ-8117) on mesangial injury induced by anti Thy-1 antibody. Jap J Pharmacol 105: 63-75, 1995.
11. Hoyer JR, Michael AF, and Hoyer LW. Immunofluorescent localization of antihemophilic factor antigen and fibrinogen in human renal diseases. J Clin Invest 53: 1375-1384, 1974.
12. Ishizaki M, Masuda Y, Fukuda Y, Sugisaki Y, Yamanaka N, and Masugi Y. Experimental mesangioproliferative glomerulonephritis in rats induced by intravenous administration of anti-thymocyte serum. Acta Pathol Jpn 36: 1191-1203, 1986.
13. Ito Y, Aten J, Bende RJ, Oemar BS, Rabelink TJ, Weening JJ, and Goldschmeding R. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 53: 853-861, 1998.
14. Ito Y, Goldschmeding R, Bende RJ, Claessen N, Chand MA, Kleij L, Rabelink TJ, Weening JJ, and Aten J. Kinetics of connective tissue growth factor expression during experimental proliferative glomerulonephritis. J Am Soc Nephrol 12: 472-484, 2001.
15. Johnson RJ, Garcia RL, Pritzl P, and Alpers CE. Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. Am J Pathol 136: 369-374, 1990.
16. Kane WH, Ichinose A, Hagen FS, and Davie EW. Cloning of cDNAs coding for the heavy chain region and connecting region of human factor V, a blood coagulation factor with four types of internal repeats. Biochemistry 26: 6508-6514, 1987.
17. Kincaid-Smith P. Coagulation and renal disease. Kidney Int 2: 183-190, 1972.
18. Klahr S, Schreiner G, and Ichikawa I. The progression of renal disease. N Engl J Med 318: 1657-1666, 1988.
19. Koffler D and Paronetto F. Immunofluorescent localization of immunoglobulins, complement, and fibrinogen in human diseases. J Clin Invest 44: 1665-1671, 1965.
20. Latta H. An approach to the structure and function of the glomerular mesangium. J Am Soc Nephrol 2: S65-S73, 1992.
21. Liu N, Ono T, Suyama K, Nogaki F, Shirakawa K, Maeda M, Kawamura T, Kamata T, Oyama A, Muso E, and Sasayama S. Mesangial factor V expression colocalized with fibrin deposition in IgA nephropathy. Kidney Int 58: 598-606, 2000.
22. Mann KG, Jenny RJ, and Krishnaswamy S. Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Anna Rev Biochem 57: 915-956, 1988.
23. Matsumori A, Ono K, Okada M, Miyamoto T, Sato Y, and Sasayama S. Immediate increase in circulating hepatocyte growth factor/scatter factor by heparin. J Mol Cell Cardiol 30: 2145-2149, 1998.
24. McLean IW and Nakane PK. Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy. J Histochem Cytochem 122: 1077-1083, 1974.
25. Mizuno S, Kurosawa T, Matsumoto K, Mizuno-Horikawa Y, Okamoto M, and Nakamura T. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J Clin Invest 101: 1827-1834, 1998.
26. Monno R, Grandaliano G, Faccio R, Ranieri E, Martine C, Gesualdo L, and Schena FP. Activated coagulation factor X: a novel Mitogenic stimulus for human mesangial cells. J Am Soc Nephrol 12: 891-899, 2001.
27. Mosley K, Collar J, and Cattell V. Mesangial cell necrosis in Thy 1 glomerulonephritis: an ultrastructural study. Virchows Arch 436: 567-573, 2000.
28. Nogaki F, Muso E, Yashiro M, Kasuno K, Kamata T, Ono T, and Sasayama S. Direct effects of simvastatin on proliferation and matrix accumulation in cultured murine mesangial cells. Clin Exp Nephrol 5: 85-89, 2001.
29. Ono T, Kanatsu K, Doi T, Sekita K, Nagai H, Muso E, Yoshida H, Tamura T, and Kawai C. Immunoelectron microscopic localization of fibrin-related antigen in human glomerular diseases. Nephron 52: 238-243, 1989.
30. Ono T, Kanatsu K, Doi T, Sekita K, Onoe C, Nagai H, Muso E, Yoshida H, Tamura T, and Kawai C. Relationship of intraglomerular coagulation and platelet aggregation to glomerular sclerosis. Nephron 58: 429-436, 1991.
31. Ono T, Liu N, Kasuno K, Kusano H, Nogaki F, Kamata T, Suyama K, Muso E, and Sasayama S. Coagulation process proceeds on cultured human mesangial cells via expression of factor V. Kidney Int 60: 1009-1017, 2001.
32. Ono T, Muso E, Suyama K, Oyama A, Matsushima H, Yashiro M, Kuwahara T, Yoshida H, Kanatsu K, and Sasayama S. Intraglomerular deposition of intact cross-linked fibrin in IgA nephropathy and Henoch-Schönlein purpura nephritis. Nephron 74: 522-528, 1996.
33. Oomura A, Nakamura T, Arakawa M, Ooshima A, and Isemura M. Alteration in the extracellular matrix components in human glomerular diseases. Virchows Arch 415: 151-159, 1989.
34. Riley SG, Evans RA, Davies M, Floege J, and Phillips AO. Goto-Kakizaki rat is protected from proteinuria after induction of anti-Thy1 nephritis. Am J Kidney Dis 39: 985-1000, 2002.
35. Tipping PG, Dowling JP, and Holdsworth SR. Glomerular procoagulant activity in human proliferative glomerulonephritis. J Clin Invest 81: 119-125, 1988.
36. Tipping PG, Erlich JH, Apostolopoulos J, Mackman N, Loskutoff D, and Holdsworth SR. Glomerular tissue factor expression in crescentic glomerulonephritis. Correlations between antigen, activity, and mRNA. Am J Pathol 147: 1736-1748, 1995.
37. Vassalli P and McCluskey RT. The pathogenetic role of the coagulation process in glomerular diseases of immunologic origin. Adv Nephrol Necker Hosp 1: 47-63, 1971.
38. Wiggins RC, Njoku N, and Sedor JR. Tissue factor production by cultured rat mesangial cells. Stimulation by TNF alpha and lipopolysaccharide. Kidney Int 37: 1281-1285, 1990.
39. Yamabe H, Osawa H, Inuma H, Kaizuka M, Tamura N, Tsunoda S, Baba Y, Shirato K, and Onodera K. Thrombin stimulates production of tranforming growth factor-beta by cultured human mesangial cells. Nephrol Dial Transplant 12: 438-442, 1997.